Sec Form 3 Filing - Garella Rahul @ Endo International plc - 2019-08-01

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Garella Rahul 2. Issuer Name and Ticker or Trading Symbol Endo International plc [ ENDP] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) EVP, Intl Pharmaceuticals (Last) (First) (Middle) C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD 3. Date of Earliest Transaction (MM/DD/YY) 08/01/2019 (Street) BALLSBRIDGE, DUBLIN, L2 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Ordinary Shares 24,116 D 2015 Stock Incentive Plan Restricted Stock Units (RSU) ( 1 ) 236 D 2015 Stock Incentive Plan Restricted Stock Units (RSU) ( 2 ) 353 D 2015 Stock Incentive Plan Restricted Stock Units (RSU) ( 3 ) 3,538 D 2015 Stock Incentive Plan Restricted Stock Units (RSU) ( 4 ) 16,047 D 2015 Stock Incentive Plan Restricted Stock Units (RSU) ( 5 ) 39,700 D 2015 Stock Incentive Plan Restricted Stock Units (RSU) ( 6 ) 26,902 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares 2015 Stock Incentive Plan Options (NQ) ( 7 ) $ 70.02 ( 7 ) 10/01/2025 Ordinary Shares 3,422 D 2015 Stock Incentive Plan Options (NQ) ( 8 ) $ 50.22 ( 8 ) 02/23/2026 Ordinary Shares 4,764 D 2015 Stock Incentive Plan Options (NQ) ( 9 ) $ 13.19 ( 9 ) 02/21/2027 Ordinary Shares 23,810 D 2015 Stock Incentive Plan Options (NQ) ( 10 ) $ 7.55 ( 10 ) 08/10/2027 Ordinary Shares 54,707 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Garella Rahul C/O ENDO INTERNATIONAL PLC FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD BALLSBRIDGE, DUBLIN, L2 EVP, Intl Pharmaceuticals Signatures /s/ Yoon Ah Oh, by power of attorney 08/09/2019 Signature of Reporting Person Date

Explanation of Responses:

( 1 )On October 1, 2015, 946 RSUs were granted to Mr. Garella with one-fourth vesting, and thus expiring, on each of the first four grant date anniversaries. As of August 1, 2019, 710 RSUs were vested and released. The amount reported in Table I represents the unvested portion as of that date. ( 2 )On February 23, 2016, 1,412 RSUs were granted to Mr. Garella with one-fourth vesting, and thus expiring, on each of the first four grant date anniversaries. As of August 1, 2019, 1,059 RSUs were vested and released. The amount reported in Table I represents the unvested portion as of that date. ( 3 )On February 21, 2017, 10,614 RSUs were granted to Mr. Garella with one-third vesting, and thus expiring, on each of the first three grant date anniversaries. As of August 1, 2019, 7,076 RSUs were vested and released. The amount reported in Table I represents the unvested portion as of that date. ( 4 )On August 10, 2017, 24,071 RSUs were granted to Mr. Garella with one-third vesting, and thus expiring, on each of the first three grant date anniversaries. As of August 1, 2019, 8,024 RSUs were vested and released. The amount reported in Table I represents the unvested portion as of that date. ( 5 )On April 2, 2018, 59,551 RSUs were granted to Mr. Garella with one-third vesting, and thus expiring, on each of the first three grant date anniversaries. As of August 1, 2019, 19,851 RSUs were vested and released. The amount reported in Table I represents the unvested portion as of that date. ( 6 )On March 29, 2019, 26,902 RSUs were granted to Mr. Garella with one-third vesting, and thus expiring, on each of the first three grant date anniversaries. ( 7 )On October 1, 2015, 3,422 non-qualified stock options were granted to Mr. Garella with one-fourth vesting on each of the first four grant date anniversaries. As of August 1, 2019, 2,567 non-qualified stock options were vested and released. ( 8 )On February 23, 2016, 4,764 non-qualified stock options were granted to Mr. Garella with one-fourth vesting on each of the first four grant date anniversaries. As of August 1, 2019, 3,573 non-qualified stock options were vested and released. ( 9 )On February 21, 2017, 23,810 non-qualified stock options were granted to Mr. Garella with one-fourth vesting on each of the first four grant date anniversaries. As of August 1, 2019, 11,906 non-qualified stock options were vested and released. ( 10 )On August 10, 2017, 54,707 non-qualified stock options were granted to Mr. Garella with one-third vesting on each of the first three grant date anniversaries. As of August 1, 2019, 18,236 non-qualified stock options were vested and released.

Remarks: On July 30, 2019, Endo International plc appointed Mr. Garella as EVP, International Pharmaceuticals. These securities represent the amounts owned by Mr. Garella as of August 1, 2019, the date of effectiveness of his appointment.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a curre ntly valid OMB Number.